RxDoctor Payments DataLook up a doctor →

David Pernikoff, MD

Internal Medicine · Saint Louis, MONPI 1205820594

Payments from drug & device makers

$17,202in general payments, 2019–2025

Across 961 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • GSK$2K
  • Lilly USA, LLC$2K
  • Novo Nordisk$1K
  • Otsuka America Pharmaceutical, Inc.$957
  • Amarin Pharma, Inc.$920
  • plus $8K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)141$2,237
GSK149$2,170
Lilly USA, LLC78$1,631
Novo Nordisk74$1,282
Otsuka America Pharmaceutical, Inc.35$957
Amarin Pharma, Inc.60$920
Pfizer60$889
Johnson & Johnson26$839
Amgen23$662
Boehringer Ingelheim32$631
Merck29$444
Sanofi-aventis U.S. LLC25$392
Novartis23$352
Bayer15$342
Takeda Pharmaceuticals U.S.A., Inc.20$296
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)11$219
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$205
Dexcom, Inc.13$200
Biogen10$198
Medtronic(2 entities)5$193
Abbott10$187
Astellas Pharma US Inc11$176
Sumitomo Pharma America, Inc.11$166
Biohaven Pharmaceuticals, Inc.4$148
E.r. Squibb & Sons, L.L.C.9$137
Exact Sciences6$127
Urovant Sciences Inc1$125
Esperion Therapeutics, Inc.8$118
Lundbeck LLC5$101
Axsome Therapeutics, Inc.5$77
Eisai Inc.5$72
Lexicon Pharmaceuticals, Inc.4$69
Kowa Pharmaceuticals America, Inc.4$61
Supernus Pharmaceuticals, Inc.4$57
Sunovion Pharmaceuticals Inc.5$56
Biohaven Pharmaceutical Holding Company Ltd.3$50
Sanofi1$36
GE HealthCare2$32
Hikma Pharmaceuticals USA2$26
Echosens North America, Inc.1$24
Ironwood Pharmaceuticals, Inc1$22
Viatris Specialty LLC1$22
Mylan Specialty L.p.1$22
Ardelyx, Inc.1$22
Corium, LLC1$21
Phathom Pharmaceuticals, Inc.1$20
Dermira, Inc.1$20
AstraZeneca1$19
Endo Pharmaceuticals Inc.1$17
Optos, Inc.1$16
Organogenesis Inc.1$15
Xeris Pharmaceuticals, Inc.1$14
Insulet Corporation1$14
Idorsia Pharmaceuticals US Inc1$14
Amneal Pharmaceuticals LLC1$13
Impel Pharmaceuticals Inc.1$13
Shire North American Group Inc1$11

How this compares

$17,202 in reported general payments places this provider in the 95th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri →

Medicare billing

Part B allowed, 2024
$54,464
Medicare patients
147
Services billed
758

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →